Table 5. Pathological grade of patients treated with neoadjuvant therapy and primary surgery applied.
p: chi-squared test
| Primary therapy type | Grade | Pre-COVID-19 | Post-COVID-19 | Total | ||||
| n | % | n | % | n | % | p | ||
| Neoadjuvant therapy | Unknown | 17 | 41.5 | 21 | 44.7 | 38 | 43.2 | 0.559 |
| 1 | 5 | 12.2 | 10 | 21.3 | 15 | 17 | ||
| 2 | 12 | 29.3 | 11 | 23.4 | 23 | 26.1 | ||
| 3 | 7 | 17.1 | 5 | 10.6 | 12 | 13.6 | ||
| Primary surgery | Unknown | 12 | 8 | 4 | 3 | 16 | 5.7 | 0.164 |
| 1 | 54 | 36 | 43 | 32.6 | 97 | 34.4 | ||
| 2 | 64 | 42.7 | 59 | 44.7 | 123 | 43.6 | ||
| 3 | 20 | 13.3 | 26 | 19.7 | 46 | 16.3 | ||